Changes

Jump to navigation Jump to search
no edit summary
Line 20: Line 20:  
::To speak more broadly: alternative medicine is a legitimate area of research. (Alternative medicine becomes relevant here because one of the most salient claims of alternative medicine as a movement is that traditional treatments end up causing more diseases than they treat.) Even some hospitals are now granting credentials to alternative practitioners and offering alternative services, now that someone has actually spent serious money to find out that many alternative therapies do work. The papers are out there for any properly industrious student to find. Therefore, one cannot reject alternative medicine out-of-hand, but everything we publish in that regard must have solid sources. Acceptable evidence can include actual experience in offering advice to patients or friends and having that advice pay off. It must, however, involve more than claims that "the regulatory agencies are in bed with the industries that they regulate." That sort of claim is more suitable for an essay than for an article."--[[User:TerryH|TerryH]]<sup>[[User talk:TerryH|Talk]]</sup> 16:45, 12 January 2009 (EST)
 
::To speak more broadly: alternative medicine is a legitimate area of research. (Alternative medicine becomes relevant here because one of the most salient claims of alternative medicine as a movement is that traditional treatments end up causing more diseases than they treat.) Even some hospitals are now granting credentials to alternative practitioners and offering alternative services, now that someone has actually spent serious money to find out that many alternative therapies do work. The papers are out there for any properly industrious student to find. Therefore, one cannot reject alternative medicine out-of-hand, but everything we publish in that regard must have solid sources. Acceptable evidence can include actual experience in offering advice to patients or friends and having that advice pay off. It must, however, involve more than claims that "the regulatory agencies are in bed with the industries that they regulate." That sort of claim is more suitable for an essay than for an article."--[[User:TerryH|TerryH]]<sup>[[User talk:TerryH|Talk]]</sup> 16:45, 12 January 2009 (EST)
   −
:::"The prevalence of MS  in Japan has not changed  over  the  past  two  decades,3,4 while  rise and  fall in SMON was synchronous with consumption of clioquinol in Japan and SMON  disappeared  when  the  drug  was  withdrawn"<ref name=Kono> "SUBACUTE MYELO-OPTIC NEUROPATHY IS NOT A SPECIAL FORM OF MULTIPLE SCLEROSIS", ''The Lancet'', Volume 320, Issue 8292, 31 July 1982, Page 267, Reisaku Kono, Yoshigoro Kuroiwa </ref>
+
:::"The prevalence of MS  in Japan has not changed  over  the  past  two  decades,3,4 while  rise and  fall in SMON was synchronous with consumption of clioquinol in Japan and SMON  disappeared  when  the  drug  was  withdrawn"  
−
:::"Several workers  have produced  in dogs  and  other animals given
+
<blockquote>
−
oral clioquinol,  pathological -  changes compatible with those  of
+
"SUBACUTE MYELO-OPTIC NEUROPATHY IS NOT A SPECIAL FORM OF MULTIPLE SCLEROSIS", ''The Lancet'', Volume 320, Issue 8292, 31 July 1982, Page 267, Reisaku Kono, Yoshigoro Kuroiwa
−
SMON. On  the one hand, comparable results have never been
+
</blockquote>  
−
achieved in animals inoculated  with  the  so-called Inoue  virus, and
+
:::"Several workers  have produced  in dogs  and  other animals givenoral clioquinol,  pathological -  changes compatible with those  of MON. On  the one hand, comparable results have never been achieved in animals inoculated  with  the  so-called Inoue  virus, and the  very  existence  of this  virus  has  been  questioned." {{unsigned|RickD}}--16:35, 12 January 2009
−
the  very  existence  of this  virus  has  been  questioned."<ref name=Kono/>
  −
{{reflist}} {{unsigned|RickD}}--16:35, 12 January 2009
 
nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW
26,487

edits

Navigation menu